These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview. Singh JA; Christensen R; Wells GA; Suarez-Almazor ME; Buchbinder R; Lopez-Olivo MA; Ghogomu ET; Tugwell P CMAJ; 2009 Nov; 181(11):787-96. PubMed ID: 19884297 [TBL] [Abstract][Full Text] [Related]
4. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139 [TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of biological treatments based on ACR70 response in rheumatoid arthritis: indirect comparison and meta-regression using Bayes-model]. Brodszky V Orv Hetil; 2011 Jun; 152(23):919-28. PubMed ID: 21592952 [TBL] [Abstract][Full Text] [Related]
7. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness simulation model of biologic strategies for treating to target rheumatoid arthritis in Germany. Beresniak A; Baerwald C; Zeidler H; Krüger K; Neubauer AS; Dupont D; Merkesdal S Clin Exp Rheumatol; 2013; 31(3):400-8. PubMed ID: 23464803 [TBL] [Abstract][Full Text] [Related]
10. The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review. Kristensen LE; Christensen R; Bliddal H; Geborek P; Danneskiold-Samsøe B; Saxne T Scand J Rheumatol; 2007; 36(6):411-7. PubMed ID: 18092260 [TBL] [Abstract][Full Text] [Related]
11. The comparison of effects of biologic agents on rheumatoid arthritis damage progression is biased by period of enrollment: data from a systematic review and meta-analysis. Favalli EG; Pregnolato F; Biggioggero M; Meroni PL Semin Arthritis Rheum; 2014 Jun; 43(6):730-7. PubMed ID: 24332807 [TBL] [Abstract][Full Text] [Related]
12. Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review. Rubbert-Roth A; Finckh A Arthritis Res Ther; 2009; 11 Suppl 1(Suppl 1):S1. PubMed ID: 19368701 [TBL] [Abstract][Full Text] [Related]
13. The yin and yang of tumor necrosis factor inhibitors. Calabrese L Cleve Clin J Med; 2006 Mar; 73(3):251-6. PubMed ID: 16548447 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of treatment intensification with adalimumab, etanercept and infliximab in rheumatoid arthritis: a systematic review of cohort studies with focus on dose. Eng G; Stoltenberg MB; Szkudlarek M; Bouchelouche PN; Christensen R; Bliddal H; Marie Bartels E Semin Arthritis Rheum; 2013 Oct; 43(2):144-51. PubMed ID: 23838092 [TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of the efficacy and safety of adalimumab, etanercept, and infliximab for the treatment of rheumatoid arthritis. Wiens A; Venson R; Correr CJ; Otuki MF; Pontarolo R Pharmacotherapy; 2010 Apr; 30(4):339-53. PubMed ID: 20334454 [TBL] [Abstract][Full Text] [Related]
16. Recurrent hepatotoxicity associated with etanercept and adalimumab but not with infliximab in a patient with rheumatoid arthritis. Titos Arcos JC; Hallal H; Robles M; Andrade RJ Rev Esp Enferm Dig; 2012 May; 104(5):282-4. PubMed ID: 22662786 [No Abstract] [Full Text] [Related]
17. [Therapeutic efficacy and the adverse effects of newly developed biological agents for rheumatoid arthritis]. Kondo H Nihon Naika Gakkai Zasshi; 2004 Jan; 93(1):153-60. PubMed ID: 14968591 [No Abstract] [Full Text] [Related]
18. Comparison between adalimumab, etanercept, and infliximab in rheumatoid arthritis: comment on the article by Hetland et al. Francis S; Block MJ Arthritis Rheum; 2010 Sep; 62(9):2826; author reply 2826-8. PubMed ID: 20556822 [No Abstract] [Full Text] [Related]
19. [Efficacy and safety of TNF inhibitors--results of randomized, controlled clinical trials vs long term observational studies]. Filipowicz-Sosnowska A; Kwiatkowska B Pol Arch Med Wewn; 2006 Oct; 116(4):980-7. PubMed ID: 18416301 [No Abstract] [Full Text] [Related]
20. [Should we be afraid of the anti-TNFalpha drugs in 2008?]. Gaudin P Rev Med Interne; 2008 Dec; 29(12):971-4. PubMed ID: 18571291 [No Abstract] [Full Text] [Related] [Next] [New Search]